How big is the veterinary therapeutics market?

HighlightsThe global Veterinary Therapeutics market was valued at US 32170 million in 2022 and is anticipated to reach US 40240 million by 2029 witnessing a CAGR of 3.8 during the forecast period 20232029.

Who are the key players in the veterinary therapeutics market?

Some of the key players are Companies, Boehringer, Others.

Global Veterinary Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Veterinary Therapeutics Market Insights, Forecast to 2029

Code: QYRE-Auto-23N13648

Report

June 2023

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Boehringer Ingelheim GmbH

Ceva Sante Animale

Dechra Pharmaceuticals Plc

Eli Lilly and Company (Elanco Animal Health)

Merck Animal Health

Sanofi (Merial Animal Health)

Virbac

Vetoquinol

Zoetis Inc

Veterinary Therapeutics Market Size

The global Veterinary Therapeutics market is projected to grow from US$ 32170 million in 2023 to US$ 40240 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

Veterinary Therapeutics Market

Market Analysis and Insights: Global Veterinary Therapeutics Market

The US & Canada market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Veterinary Therapeutics include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac and Vetoquinol S.A., etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Veterinary Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Veterinary Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Veterinary Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Veterinary Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Veterinary Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac and Vetoquinol S.A., etc.

Scope of Veterinary Therapeutics Market Report

Report Metric	Details
Report Name	Veterinary Therapeutics Market
Accounted market size in 2023	US$ 32170 million
Forecasted market size in 2029	US$ 40240 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Anti-inflammatory Parasiticides Others
Segment by Application	Hospitals Veterinary Clinics Drug Stores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac, Vetoquinol S.A., Zoetis, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Veterinary Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Anti-inflammatory

1.2.3 Parasiticides

1.2.4 Others

1.3 Market by Application

1.3.1 Global Veterinary Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Veterinary Clinics

1.3.4 Drug Stores

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Veterinary Therapeutics Market Perspective (2018-2029)

2.2 Global Veterinary Therapeutics Growth Trends by Region

2.2.1 Veterinary Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Veterinary Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Veterinary Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Veterinary Therapeutics Market Dynamics

2.3.1 Veterinary Therapeutics Industry Trends

2.3.2 Veterinary Therapeutics Market Drivers

2.3.3 Veterinary Therapeutics Market Challenges

2.3.4 Veterinary Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Veterinary Therapeutics by Players

3.1.1 Global Veterinary Therapeutics Revenue by Players (2018-2023)

3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Veterinary Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Veterinary Therapeutics Market Concentration Ratio

3.4.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2022

3.5 Global Key Players of Veterinary Therapeutics Head office and Area Served

3.6 Global Key Players of Veterinary Therapeutics, Product and Application

3.7 Global Key Players of Veterinary Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Veterinary Therapeutics Breakdown Data by Type

4.1 Global Veterinary Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2024-2029)

5 Veterinary Therapeutics Breakdown Data by Application

5.1 Global Veterinary Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Veterinary Therapeutics Market Size (2018-2029)

6.2 North America Veterinary Therapeutics Market Size by Type

6.2.1 North America Veterinary Therapeutics Market Size by Type (2018-2023)

6.2.2 North America Veterinary Therapeutics Market Size by Type (2024-2029)

6.2.3 North America Veterinary Therapeutics Market Share by Type (2018-2029)

6.3 North America Veterinary Therapeutics Market Size by Application

6.3.1 North America Veterinary Therapeutics Market Size by Application (2018-2023)

6.3.2 North America Veterinary Therapeutics Market Size by Application (2024-2029)

6.3.3 North America Veterinary Therapeutics Market Share by Application (2018-2029)

6.4 North America Veterinary Therapeutics Market Size by Country

6.4.1 North America Veterinary Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Veterinary Therapeutics Market Size by Country (2018-2023)

6.4.3 North America Veterinary Therapeutics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Veterinary Therapeutics Market Size (2018-2029)

7.2 Europe Veterinary Therapeutics Market Size by Type

7.2.1 Europe Veterinary Therapeutics Market Size by Type (2018-2023)

7.2.2 Europe Veterinary Therapeutics Market Size by Type (2024-2029)

7.2.3 Europe Veterinary Therapeutics Market Share by Type (2018-2029)

7.3 Europe Veterinary Therapeutics Market Size by Application

7.3.1 Europe Veterinary Therapeutics Market Size by Application (2018-2023)

7.3.2 Europe Veterinary Therapeutics Market Size by Application (2024-2029)

7.3.3 Europe Veterinary Therapeutics Market Share by Application (2018-2029)

7.4 Europe Veterinary Therapeutics Market Size by Country

7.4.1 Europe Veterinary Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Veterinary Therapeutics Market Size by Country (2018-2023)

7.4.3 Europe Veterinary Therapeutics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Veterinary Therapeutics Market Size (2018-2029)

8.2 China Veterinary Therapeutics Market Size by Type

8.2.1 China Veterinary Therapeutics Market Size by Type (2018-2023)

8.2.2 China Veterinary Therapeutics Market Size by Type (2024-2029)

8.2.3 China Veterinary Therapeutics Market Share by Type (2018-2029)

8.3 China Veterinary Therapeutics Market Size by Application

8.3.1 China Veterinary Therapeutics Market Size by Application (2018-2023)

8.3.2 China Veterinary Therapeutics Market Size by Application (2024-2029)

8.3.3 China Veterinary Therapeutics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Veterinary Therapeutics Market Size (2018-2029)

9.2 Asia Veterinary Therapeutics Market Size by Type

9.2.1 Asia Veterinary Therapeutics Market Size by Type (2018-2023)

9.2.2 Asia Veterinary Therapeutics Market Size by Type (2024-2029)

9.2.3 Asia Veterinary Therapeutics Market Share by Type (2018-2029)

9.3 Asia Veterinary Therapeutics Market Size by Application

9.3.1 Asia Veterinary Therapeutics Market Size by Application (2018-2023)

9.3.2 Asia Veterinary Therapeutics Market Size by Application (2024-2029)

9.3.3 Asia Veterinary Therapeutics Market Share by Application (2018-2029)

9.4 Asia Veterinary Therapeutics Market Size by Region

9.4.1 Asia Veterinary Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Veterinary Therapeutics Market Size by Region (2018-2023)

9.4.3 Asia Veterinary Therapeutics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Veterinary Therapeutics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Veterinary Therapeutics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Details

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Veterinary Therapeutics Introduction

11.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2018-2023)

11.1.5 Bayer AG Recent Developments

11.2 Boehringer Ingelheim GmbH

11.2.1 Boehringer Ingelheim GmbH Company Details

11.2.2 Boehringer Ingelheim GmbH Business Overview

11.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction

11.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2018-2023)

11.2.5 Boehringer Ingelheim GmbH Recent Developments

11.3 Ceva Sante Animale

11.3.1 Ceva Sante Animale Company Details

11.3.2 Ceva Sante Animale Business Overview

11.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction

11.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2018-2023)

11.3.5 Ceva Sante Animale Recent Developments

11.4 Dechra Pharmaceuticals PLC

11.4.1 Dechra Pharmaceuticals PLC Company Details

11.4.2 Dechra Pharmaceuticals PLC Business Overview

11.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction

11.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2018-2023)

11.4.5 Dechra Pharmaceuticals PLC Recent Developments

11.5 Eli Lilly and Company (Elanco Animal Health)

11.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details

11.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview

11.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction

11.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2018-2023)

11.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Developments

11.6 Merck Animal Health

11.6.1 Merck Animal Health Company Details

11.6.2 Merck Animal Health Business Overview

11.6.3 Merck Animal Health Veterinary Therapeutics Introduction

11.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2018-2023)

11.6.5 Merck Animal Health Recent Developments

11.7 Sanofi (Merial Animal Health)

11.7.1 Sanofi (Merial Animal Health) Company Details

11.7.2 Sanofi (Merial Animal Health) Business Overview

11.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction

11.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2018-2023)

11.7.5 Sanofi (Merial Animal Health) Recent Developments

11.8 Virbac

11.8.1 Virbac Company Details

11.8.2 Virbac Business Overview

11.8.3 Virbac Veterinary Therapeutics Introduction

11.8.4 Virbac Revenue in Veterinary Therapeutics Business (2018-2023)

11.8.5 Virbac Recent Developments

11.9 Vetoquinol S.A.

11.9.1 Vetoquinol S.A. Company Details

11.9.2 Vetoquinol S.A. Business Overview

11.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction

11.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2018-2023)

11.9.5 Vetoquinol S.A. Recent Developments

11.10 Zoetis, Inc.

11.10.1 Zoetis, Inc. Company Details

11.10.2 Zoetis, Inc. Business Overview

11.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction

11.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2018-2023)

11.10.5 Zoetis, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bayer

Boehringer Ingelheim GmbH

Ceva Sante Animale

Dechra Pharmaceuticals Plc

Eli Lilly and Company (Elanco Animal Health)

Merck Animal Health

Sanofi (Merial Animal Health)

Virbac

Vetoquinol

Zoetis Inc

List of Tables

Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Anti-inflammatory

Table 3. Key Players of Parasiticides

Table 4. Key Players of Others

Table 5. Global Veterinary Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 6. Global Veterinary Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Veterinary Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Veterinary Therapeutics Market Share by Region (2018-2023)

Table 9. Global Veterinary Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Veterinary Therapeutics Market Share by Region (2024-2029)

Table 11. Veterinary Therapeutics Market Trends

Table 12. Veterinary Therapeutics Market Drivers

Table 13. Veterinary Therapeutics Market Challenges

Table 14. Veterinary Therapeutics Market Restraints

Table 15. Global Veterinary Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Veterinary Therapeutics Revenue Share by Players (2018-2023)

Table 17. Global Top Veterinary Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2022)

Table 18. Global Veterinary Therapeutics Industry Ranking 2021 VS 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Veterinary Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 20. Global Key Players of Veterinary Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Veterinary Therapeutics, Product and Application

Table 22. Global Key Players of Veterinary Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Veterinary Therapeutics Revenue Market Share by Type (2018-2023)

Table 26. Global Veterinary Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Veterinary Therapeutics Revenue Market Share by Type (2024-2029)

Table 28. Global Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Veterinary Therapeutics Revenue Share by Application (2018-2023)

Table 30. Global Veterinary Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Veterinary Therapeutics Revenue Share by Application (2024-2029)

Table 32. North America Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 33. North America Veterinary Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 34. North America Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 35. North America Veterinary Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 36. North America Veterinary Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. North America Veterinary Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 38. North America Veterinary Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 39. Europe Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 40. Europe Veterinary Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 41. Europe Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 42. Europe Veterinary Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 43. Europe Veterinary Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Europe Veterinary Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 45. Europe Veterinary Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 46. China Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 47. China Veterinary Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 48. China Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 49. China Veterinary Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 50. Asia Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 51. Asia Veterinary Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 52. Asia Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 53. Asia Veterinary Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 54. Asia Veterinary Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 55. Asia Veterinary Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 56. Asia Veterinary Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Veterinary Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 62. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 64. Bayer AG Company Details

Table 65. Bayer AG Business Overview

Table 66. Bayer AG Veterinary Therapeutics Product

Table 67. Bayer AG Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 68. Bayer AG Recent Developments

Table 69. Boehringer Ingelheim GmbH Company Details

Table 70. Boehringer Ingelheim GmbH Business Overview

Table 71. Boehringer Ingelheim GmbH Veterinary Therapeutics Product

Table 72. Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 73. Boehringer Ingelheim GmbH Recent Developments

Table 74. Ceva Sante Animale Company Details

Table 75. Ceva Sante Animale Business Overview

Table 76. Ceva Sante Animale Veterinary Therapeutics Product

Table 77. Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 78. Ceva Sante Animale Recent Developments

Table 79. Dechra Pharmaceuticals PLC Company Details

Table 80. Dechra Pharmaceuticals PLC Business Overview

Table 81. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product

Table 82. Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 83. Dechra Pharmaceuticals PLC Recent Developments

Table 84. Eli Lilly and Company (Elanco Animal Health) Company Details

Table 85. Eli Lilly and Company (Elanco Animal Health) Business Overview

Table 86. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product

Table 87. Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 88. Eli Lilly and Company (Elanco Animal Health) Recent Developments

Table 89. Merck Animal Health Company Details

Table 90. Merck Animal Health Business Overview

Table 91. Merck Animal Health Veterinary Therapeutics Product

Table 92. Merck Animal Health Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 93. Merck Animal Health Recent Developments

Table 94. Sanofi (Merial Animal Health) Company Details

Table 95. Sanofi (Merial Animal Health) Business Overview

Table 96. Sanofi (Merial Animal Health) Veterinary Therapeutics Product

Table 97. Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 98. Sanofi (Merial Animal Health) Recent Developments

Table 99. Virbac Company Details

Table 100. Virbac Business Overview

Table 101. Virbac Veterinary Therapeutics Product

Table 102. Virbac Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 103. Virbac Recent Developments

Table 104. Vetoquinol S.A. Company Details

Table 105. Vetoquinol S.A. Business Overview

Table 106. Vetoquinol S.A. Veterinary Therapeutics Product

Table 107. Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 108. Vetoquinol S.A. Recent Developments

Table 109. Zoetis, Inc. Company Details

Table 110. Zoetis, Inc. Business Overview

Table 111. Zoetis, Inc. Veterinary Therapeutics Product

Table 112. Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2018-2023) & (US$ Million)

Table 113. Zoetis, Inc. Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Veterinary Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Veterinary Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. Anti-inflammatory Features

Figure 4. Parasiticides Features

Figure 5. Others Features

Figure 6. Global Veterinary Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 7. Global Veterinary Therapeutics Market Share by Application: 2022 VS 2029

Figure 8. Hospitals Case Studies

Figure 9. Veterinary Clinics Case Studies

Figure 10. Drug Stores Case Studies

Figure 11. Others Case Studies

Figure 12. Veterinary Therapeutics Report Years Considered

Figure 13. Global Veterinary Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Veterinary Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Veterinary Therapeutics Market Share by Region: 2022 VS 2029

Figure 16. Global Veterinary Therapeutics Market Share by Players in 2022

Figure 17. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2022

Figure 19. North America Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Veterinary Therapeutics Market Share by Type (2018-2029)

Figure 21. North America Veterinary Therapeutics Market Share by Application (2018-2029)

Figure 22. North America Veterinary Therapeutics Market Share by Country (2018-2029)

Figure 23. United States Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Veterinary Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Veterinary Therapeutics Market Share by Type (2018-2029)

Figure 27. Europe Veterinary Therapeutics Market Share by Application (2018-2029)

Figure 28. Europe Veterinary Therapeutics Market Share by Country (2018-2029)

Figure 29. Germany Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Veterinary Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Veterinary Therapeutics Market Share by Type (2018-2029)

Figure 37. China Veterinary Therapeutics Market Share by Application (2018-2029)

Figure 38. Asia Veterinary Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Veterinary Therapeutics Market Share by Type (2018-2029)

Figure 40. Asia Veterinary Therapeutics Market Share by Application (2018-2029)

Figure 41. Asia Veterinary Therapeutics Market Share by Region (2018-2029)

Figure 42. Japan Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Veterinary Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Veterinary Therapeutics Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Veterinary Therapeutics Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Veterinary Therapeutics Market Share by Country (2018-2029)

Figure 52. Brazil Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Veterinary Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Bayer AG Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 60. Ceva Sante Animale Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 61. Dechra Pharmaceuticals PLC Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 62. Eli Lilly and Company (Elanco Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 63. Merck Animal Health Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 64. Sanofi (Merial Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 65. Virbac Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 66. Vetoquinol S.A. Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 67. Zoetis, Inc. Revenue Growth Rate in Veterinary Therapeutics Business (2018-2023)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Veterinary Therapeutics Market Insights, Forecast to 2029

Published Date: June 2023

Report Code: QYRE-Auto-23N13648

Global Veterinary Therapeutics Market Insights, Forecast to 2029

FEATURED COMPANIES

Veterinary Therapeutics Market Size

Veterinary Therapeutics Market

Scope of Veterinary Therapeutics Market Report

Chapter Outline

FEATURED COMPANIES